| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| 2020 | 2016 | INBIOS INTERNATIONAL INC | 307 WESTLAKE AVE N STE 300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 5 | 12/10/2019 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| 2018 | 2016 | INBIOS INTERNATIONAL, INC | 562 1ST AVE S STE 600 | SEATTLE | WA | 98104 | KING | USA | Allergy and Infectious Diseases Research | 000 | 5 | 6/19/2018 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $700,138 ) |
| 2016 | 2016 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | Allergy and Infectious Diseases Research | 000 | 5 | 6/20/2016 | NON-COMPETING CONTINUATION | $700,138 |
|
| Issue Date FY: 2015 ( Subtotal = $673,521 ) |
| 2015 | 2015 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | Allergy and Infectious Diseases Research | 000 | 4 | 6/8/2015 | NON-COMPETING CONTINUATION | $673,521 |
|
| Issue Date FY: 2014 ( Subtotal = $621,080 ) |
| 2014 | 2014 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | Allergy and Infectious Diseases Research | 000 | 3 | 7/1/2014 | COMPETING CONTINUATION | $621,080 |
|
|